Table:
begin	end	state
1	21	signal peptide
22	251	non-cytoplasmic
252	276	transmembrane
277	287	cytoplasmic
288	312	transmembrane
313	323	non-cytoplasmic
324	348	transmembrane
349	367	cytoplasmic
368	388	transmembrane
389	404	non-cytoplasmic
405	424	transmembrane
425	434	cytoplasmic
435	462	transmembrane
463	481	non-cytoplasmic
482	501	transmembrane
502	507	cytoplasmic
508	528	transmembrane
529	547	non-cytoplasmic
548	570	transmembrane
571	580	cytoplasmic

Input:
>AZOBR_RS32335
MANMLAVIAAGDLSTQAVLAAEALRKAAAALGHTIQVEVRSSLGVRNTLPTGAAQGAQGV
ILVGSGDLGEERFAGLKRSAAALDAVLRDARAVLEQALATAPAQAPAQTGTKKIVAITSC
PTGIAHTFMAAEGIQQAAQALGHAVRVETQGSVGARDTLTEQEIREADVVLIAADTQVDL
ARFAGKRVFKSGTKPAINDGRALVERALAEAQPHGTAPALADGVAAGKAAKAEHAAAQRS
GPYKHLMTGVSFMLPFVVTGGLLIAIAFALGGIYVFEDSQQGTLGNALFQIGAKGAFALM
VPALAGYIAFSIADRPGITPGMVGGILAANLGAGFLGGIVAGFIAGYATSFLNRNIRLHK
NLEGLKPVLILPLLGSLVTGLAMIYVVGAPVAEALATLSAWLKGMQGSSAILLGLLIGAM
MAFDMGGPVNKAAYAFSTGLIASQVYTPMAAAMAAGMVPPLGLALATKLFADRFTREERE
AGNAAGILGIAFITEGAIPFAARDPLRVIPALVLGAALTGAISMGIGAELKVPHGGIFVL
PIPNAVTHLAGYVVALVAGTVTTAVALRFLKRPVSSVVTA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server